TAK - Takeda Pharmaceutical Co - ADR
Close
14.89
-0.060 -0.403%
Share volume: 1,859,532
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$14.95
-0.06
-0.40%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 2022-11-04 | 2023-02-07 | 2023-06-28 | 2023-07-27 | 2023-10-30 | 2024-02-01 | 2024-06-26 | 2024-07-31 | |
| Total revenue | 6.932 B | 8.363 B | 7.919 B | 7.316 B | 6.983 B | 7.879 B | 5.994 B | 7.508 B | |
| Cost of revenue | 2.112 B | 2.562 B | 2.551 B | 2.219 B | 2.300 B | 2.691 B | 2.217 B | 2.405 B | |
| Gross profit | 4.819 B | 5.801 B | 5.368 B | 5.097 B | 4.683 B | 5.188 B | 3.778 B | 5.103 B | |
| 20.36% | -7.46% | -5.06% | -8.12% | 10.80% | -27.19% | 35.08% | |||
| Operating expenses | 2.786 B | 3.332 B | 3.417 B | 2.839 B | 2.925 B | 3.226 B | 2.796 B | 2.726 B | |
| Selling general and admin | 1.720 B | 2.001 B | 2.096 B | 1.715 B | 1.693 B | 1.897 B | 1.658 B | 1.678 B | |
| Research and development | 1.066 B | 1.332 B | 1.321 B | 1.125 B | 1.231 B | 1.329 B | 1.138 B | 1.047 B | |
| Total expenses | 5.889 B | 6.942 B | 7.142 B | 5.956 B | 6.820 B | 6.882 B | 5.867 B | 6.147 B | |
| 17.88% | 2.88% | -16.62% | 14.51% | 0.92% | -14.75% | 4.77% | |||
| Operating income | 1.043 B | 1.421 B | 776.698 M | 1.360 B | 163.294 M | 996.915 M | 127.244 M | 1.361 B | |
| Ebit | 1.043 B | 1.421 B | 776.698 M | 1.360 B | 163.294 M | 996.915 M | 127.244 M | 1.361 B | |
| Pretax income | 446.399 M | 817.244 M | 422.904 M | 933.154 M | -642.544 M | 434.384 M | -376.175 M | 849.066 M | |
| 83.07% | -48.25% | 120.65% | -168.86% | -167.60% | -186.60% | -325.71% | |||
| Income tax | 19.482 M | -91.492 M | 139.725 M | 315.308 M | -321.399 M | -315.518 M | -282.349 M | 256.730 M | |
| Net income basic | 427.000 M | 908.569 M | 283.171 M | 617.770 M | -321.540 M | 749.654 M | -93.966 M | 592.025 M | |
| 112.78% | -68.83% | 118.16% | -152.05% | 333.15% | -112.53% | 730.04% | |||
| Net income | 427.000 M | 908.569 M | 283.171 M | 617.770 M | -321.540 M | 749.654 M | -93.966 M | 592.025 M | |
| 112.78% | -68.83% | 118.16% | -152.05% | 333.15% | -112.53% | 730.04% |